The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy

Journal of Diabetes and its Complications

Volumn 23, Issue 5, 2009, Pages 365-370

  Soliman, Osama I I ^a   van Dalen, Bas M ^a   Theuns, Dominic A M J ^a   ten Cate, Folkert J ^a   Nemes, Attila ^a   Jordaens, Luc J ^a   Geleijnse, Marcel L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac resynchronization therapy; Diabetes; Echocardiography; Heart failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART PERFORMANCE; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING;

AGED; CHI-SQUARE DISTRIBUTION; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PACEMAKER, ARTIFICIAL; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR REMODELING;

EID: 69249103863     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.04.003     Document Type: Article

References (17)

1. Bell D.S. Heart failure: The frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26 (2003) 2433-2441
2. Bleeker G.B., Kaandorp T.A., Lamb H.J., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113 (2006) 969-976
3. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Journal of the American Society of Echocardiography 16 (2003) 1091-1110
4. Helmcke F., Nanda N.C., Hsiung M.C., et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75 (1987) 175-183
5. Hoppe U.C., Freemantle N., Cleland J.G., Marijianowski M., and Erdmann E. Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure. Diabetes Care 30 (2007) 722-724
6. Kies P., Bax J.J., Molhoek S.G., et al. Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus. American Journal of Cardiology 96 (2005) 108-111
7. Mangiavacchi M., Gasparini M., Faletra F., et al. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. American Heart Journal 151 (2006) 477.e1-477.e6
8. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., and Quinones M.A. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. Journal of the American College of Cardiology 30 (1997) 1527-1533
9. Pocock S.J., Wang D., Pfeffer M.A., et al. Predictors of mortality and morbidity in patients with chronic heart failure. European Heart Journal 27 (2006) 65-75
10. Quinones M.A., Otto C.M., Stoddard M., Waggoner A., and Zoghbi W.A. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography 15 (2002) 167-184
11. Rivero-Ayerza M., Theuns D.A., Garcia-Garcia H.M., Boersma E., Simoons M., and Jordaens L.J. Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-analysis of randomized controlled trials. European Heart Journal 27 (2006) 2682-2688
12. Soliman O.I., Theuns D.A., Cate F.J., et al. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or non-ischemic etiology. American Journal of Cardiology 100 (2007) 464-469
13. Soliman O.I., Theuns D.A., Geleijnse M.L., et al. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy. Europace 9 (2007) 113-118
14. Soliman O.I., Theuns D.A., Ten Cate F.J., et al. Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parameters. Journal of Cardiac Failure 13 (2007) 805-811
15. Sutton M.G., Plappert T., Hilpisch K.E., Abraham W.T., Hayes D.L., and Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113 (2006) 266-272
16. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European Heart Journal 26 (2005) 1115-1140
17. Tei C., Ling L.H., Hodge D.O., et al. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function-A study in normals and dilated cardiomyopathy. Journal of Cardiology 26 (1995) 357-366